Aspire Mucus and Pain Relief Softgels

Product NDC
81013-105
Requested package NDC
81013-105-01
11-digit product format
810130105
Labeler code
81013
Product ID
81013-105_dbc83501-9402-2a8d-e053-2a95a90a45c5
Type
HUMAN OTC DRUG
Nonproprietary name
Aspire Mucus and Pain Relief Softgels
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Labeler
Aspire Pharmaceuticals Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2022-04-14
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; GUAIFENESIN
Active strength
325 mg/1; mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage81013-10581013-105-01UExcluded because listing certification expiredexcluded / ndc_excluded.zip302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage81013-10581013-105-01UExcluded because listing certification expiredexcluded / ndc_excluded.ziped331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage81013-10581013-105-01UExcluded because listing certification expiredexcluded / ndc_excluded.zip0efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81013-105-012025-01-30C16284748780-12cef2736-7426-d83d-e063-dadaa90ab31fdbc83501-9401-2a8d-e053-2a95a90a45c5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
81013-105-01810130105016000 CAPSULE, LIQUID FILLED in 1 BAG (81013-105-01) 2022-04-140000-00-00NoNoCurrent